{"entity":{"type":"insider","cik":"0001688104","url":"/insider/0001688104","json_url":"/insider/0001688104.json","name":"Barbo William D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":204,"n_filings":17,"first":"2017-03-07","last":"2024-02-23","span_basis":"filed_date"},"name_variants":[{"name":"Barbo William D","source":"filing","n_filings":17,"first_seen":"2017-03-07","last_seen":"2024-02-23"}],"transactions":[{"id":3155454,"accession":"0001127602-24-006706","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-006706","line_url":"/filing/0001127602-24-006706#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001688104","owner_name":"Barbo William D","owner_display_name":"Barbo William D","owner_url":"/insider/0001688104","role":"Officer (Corporate Executive VP & CCO)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4050.0,"shares_display":"4,050","price_per_share":248.5,"price_display":"248.50","price_state":"stated","total_value":1006425.0,"total_display":"1,006,425.00","total_whole":"1,006,425","shares_owned_after":22879.0,"shares_owned_after_display":"22,879","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-22","filed_date":"2024-02-23","scope":"insider"},{"id":7806703,"accession":"0001127602-23-022488","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-022488","line_url":"/filing/0001127602-23-022488#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001688104","owner_name":"Barbo William D","owner_display_name":"Barbo William D","owner_url":"/insider/0001688104","role":"Officer (Corporate Executive VP & CCO)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5763.0,"shares_display":"5,763","price_per_share":217.24,"price_display":"217.24","price_state":"stated","total_value":1251954.12,"total_display":"1,251,954.12","total_whole":"1,251,954","shares_owned_after":3592.0,"shares_owned_after_display":"3,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-10","filed_date":"2023-08-14","scope":"insider"},{"id":6320345,"accession":"0000950103-22-020817","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950103-22-020817","line_url":"/filing/0000950103-22-020817","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001688104","owner_name":"Barbo William D","owner_display_name":"Barbo William D","owner_url":"/insider/0001688104","role":"Officer (Corporate Executive VP & CCO)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3205.0,"shares_display":"3,205","price_per_share":219.91079048361934,"price_display":"219.91","price_state":"stated","total_value":704814.0835,"total_display":"704,814.08","total_whole":"704,814","shares_owned_after":4503.0,"shares_owned_after_display":"4,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-06","scope":"insider","n_lines":4},{"id":4778090,"accession":"0001127602-21-023431","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001127602-21-023431","line_url":"/filing/0001127602-21-023431","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001688104","owner_name":"Barbo William D","owner_display_name":"Barbo William D","owner_url":"/insider/0001688104","role":"Officer (Corporate Executive VP & CCO)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12387.0,"shares_display":"12,387","price_per_share":402.82163379349316,"price_display":"402.82","price_state":"stated","total_value":4989751.5778,"total_display":"4,989,751.58","total_whole":"4,989,752","shares_owned_after":10561.0,"shares_owned_after_display":"10,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-06","filed_date":"2021-08-10","scope":"insider","n_lines":9},{"id":5371387,"accession":"0001127602-21-008726","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-21-008726","line_url":"/filing/0001127602-21-008726","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001688104","owner_name":"Barbo William D","owner_display_name":"Barbo William D","owner_url":"/insider/0001688104","role":"Officer (Corporate Executive VP & CCO)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4650.0,"shares_display":"4,650","price_per_share":290.1806063655914,"price_display":"290.18","price_state":"stated","total_value":1349339.8196,"total_display":"1,349,339.82","total_whole":"1,349,340","shares_owned_after":3818.0,"shares_owned_after_display":"3,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider","n_lines":2},{"id":2972074,"accession":"0001127602-20-028232","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-20-028232","line_url":"/filing/0001127602-20-028232#line-4","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001688104","owner_name":"Barbo William D","owner_display_name":"Barbo William D","owner_url":"/insider/0001688104","role":"Officer (Corporate Executive VP & CCO)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2150.0,"shares_display":"2,150","price_per_share":236.2861,"price_display":"236.29","price_state":"stated","total_value":508015.115,"total_display":"508,015.12","total_whole":"508,015","shares_owned_after":9821.0,"shares_owned_after_display":"9,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-05","scope":"insider"},{"id":2426935,"accession":"0001127602-20-009777","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-20-009777","line_url":"/filing/0001127602-20-009777","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001688104","owner_name":"Barbo William D","owner_display_name":"Barbo William D","owner_url":"/insider/0001688104","role":"Officer (Corporate Executive VP & CCO)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13966.0,"shares_display":"13,966","price_per_share":164.34910881426322,"price_display":"164.35","price_state":"stated","total_value":2295299.6537,"total_display":"2,295,299.65","total_whole":"2,295,300","shares_owned_after":21240.0,"shares_owned_after_display":"21,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-05","filed_date":"2020-03-06","scope":"insider","n_lines":2},{"id":2923598,"accession":"0001127602-20-005459","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-005459","line_url":"/filing/0001127602-20-005459#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001688104","owner_name":"Barbo William D","owner_display_name":"Barbo William D","owner_url":"/insider/0001688104","role":"Officer (Corporate Executive VP & CCO)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6901.0,"shares_display":"6,901","price_per_share":172.1053,"price_display":"172.11","price_state":"stated","total_value":1187698.6753,"total_display":"1,187,698.68","total_whole":"1,187,699","shares_owned_after":18931.0,"shares_owned_after_display":"18,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-13","filed_date":"2020-02-14","scope":"insider"},{"id":8125485,"accession":"0001127602-19-020216","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001127602-19-020216","line_url":"/filing/0001127602-19-020216","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL INC","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001688104","owner_name":"Barbo William D","owner_display_name":"Barbo William D","owner_url":"/insider/0001688104","role":"Officer (Corporate Executive VP & CCO)","role_mark":"O","role_mark_label":"Officer (Corporate Executive VP & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Executive VP & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4905.0,"shares_display":"4,905","price_per_share":125.16189908256881,"price_display":"125.16","price_state":"stated","total_value":613919.115,"total_display":"613,919.12","total_whole":"613,919","shares_owned_after":24489.0,"shares_owned_after_display":"24,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-29","filed_date":"2019-05-30","scope":"insider","n_lines":29}],"collapsed":true,"next_cursor":"2019-05-29|8125410","ledger_fault":false,"count":{"value":204,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":204,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":204},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001100682","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","url":"/issuer/0001100682","role":"Officer (Corporate Executive VP & CCO)","n_filings":17,"first_seen":"2017-03-07","last_seen":"2024-02-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001688104","retrieved_at":"2026-08-24T10:12:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}